EN
HI
Parmax Pharma share price chart
Parmax Pharma Share Key Metrics
Volume
1279.00
Market Cap
46.75 CR
LTQ@LTP
275@124.95
ATP
124.95
Var Margin
100 %
Circuit Range
120.05-124.95
Delivery %
100 %
Value
1.60 L
ASM/GSM
No
Market Lot
1
Summary
PARMAX stock price is ₹124.95 as of 19 Aug, 2026. The stock intraday movement has stayed between ₹124.95 and ₹124.95, while Parmax Pharma share price 52 week high low is ₹22.60 & ₹124.95.
In terms of trading activity, PARMAX share price has recorded a volume of 1,279 shares. The Parmax Pharma has a market cap of ₹3741300. The stock’s Average Traded Price (ATP) stands at ₹124.95, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 275 @ ₹124.95.
The Parmax Pharma upper circuit limit is ₹124.95 & The Parmax Pharma lower circuit limit is ₹120.05, with a Value of ₹1.60 L. The Delivery Percentage for the day is 100%.
Additionally, the share currently falls under the No framework, and trades with a market lot size of ₹1.
Parmax Pharma Fundamentals
P/E Ratio
0
P/B Ratio
0
Div. Yield
0
Sector P/E
64.9
Sector P/B
3.32
Sec. Div. Yield
0.51
Parmax Pharma Resistance and Support
Pivot 122.33
Resistance
First Resistance
122.66
Second Resistance
122.83
Third Resistance
123.16
Support
First Support
122.16
Second Support
121.83
Third Support
121.66
Parmax Pharma Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Wed Aug 19 2026 | 124.95 | 124.95 | 2.00% | 124.95 | 124.95 |
| Tue Aug 18 2026 | 122.5 | 122.5 | 2.01% | 122.5 | 122 |
| Mon Aug 17 2026 | 120.09 | 120.09 | 1.99% | 120.09 | 120.09 |
Parmax Pharma Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-14 | Quarterly Results |
| 2026-06-08 | Fund raising |
| 2026-06-02 | Audited Results |
| 2026-05-30 | Audited Results |
| 2026-02-14 | Quarterly Results |
| 2025-11-14 | Quarterly Results |
| 2025-08-14 | Quarterly Results |
| 2025-05-30 | Audited Results |
| 2025-02-14 | Quarterly Results |
| 2024-11-14 | Quarterly Results |
| 2024-08-14 | Quarterly Results |
Parmax Pharma News
Parmax Pharma Ltd - 540359 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Parmax Pharma's promoters, including Alkesh Mahasukhlal Gopani, sold their entire 30.81% stake, totaling 11.52 lakh shares, on August 13, 2026. This significant off-market disposal signals a complete exit by the promoter group.
Aug 17 2026 15:05:36
Parmax Pharma Ltd - 540359 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Dhiren Chandulal Shah and a group of Persons Acting in Concert (PACs) have acquired 11.52 lakh equity shares of Parmax Pharma through an off-market transaction. This acquisition increases their collective holding in the company by 30.81%, from 27.20% to 58.01%.
Aug 17 2026 14:25:05
Read More
Parmax Pharma Management
| Name | Position |
|---|---|
| Umang A Gosalia | Managing Director |
| Nikhil Uchat | Non Executive Independent Director |
Parmax Pharma Similar Stocks
Beryl Drugs Ltd.
22.15
-0.85 (3.70%)
Sharma East India Hospitals & Medical Research Ltd
95.00
-2.91 (2.97%)
Norris Medicines Ltd.
16.34
0.00 (0.00%)
Soni Medicare Ltd.
0.00
0.00 (0.00%)
Colinz Laboratories Ltd.
80.00
0.00 (0.00%)
Broach Lifecare Hospital Ltd.
18.20
0.00 (0.00%)
Unjha Formulations Ltd.
26.13
-1.36 (4.95%)
Starsource Multitrade Ltd.
92.99
2.53 (2.80%)
Ortin Global Ltd.
15.14
0.00 (0.00%)
Parmax Pharma FAQs
The Buying Price of Parmax Pharma share is 124.95 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Parmax Pharma stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Parmax Pharma, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Parmax Pharma shares is 0. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Parmax Pharma shares is 0. Useful to assess the stock's value relative to its book value.
To assess Parmax Pharma’s valuation compare Sector P/E, P/B which are 64.9 & 3.32 with sector averages, along with growth rates and financial metrics.
The Market Cap of Parmax Pharma is 46.75 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Parmax Pharma share price is 124.95 & 22.60. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Parmax Pharma belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
